Press Releases from Biopharma PEG Scientific Inc (15 total)
BIOPHARMA PEG Receives FDA DMF Listings for Two Key PEG Derivatives
BIOPHARMA PEG, a leading developer and supplier of high-purity polyethylene glycol (PEG) derivatives, today announced that two of its proprietary products-mPEG-pALD 20K and HZ-PEG-HZ (1K)-have…
Monodispersed PEG Linkers Enhance Antibody-Drug Conjugates (ADCs)
Antibody-drug conjugates (ADCs) combine potent small-molecule drugs with monoclonal antibodies for targeted cancer therapy. A major challenge is loading enough drug onto each antibody without…
Biopharma PEG Scientific Inc. to Showcase Comprehensive PEG Derivative Portfolio …
Biopharma PEG Scientific Inc., a leading provider of high-quality polyethylene glycol (PEG) derivatives, today announced its participation in TIDES USA 2025, taking place from May…
BIOPHARMA PEG Showcases DSPE-PEG-Mannose: A Cutting-Edge Polymer for Drug Delive …
Watertown, MA - March 24, 2025 - Biopharma PEG, a leading supplier of high-quality polyethylene glycol (PEG) derivatives, highlights its innovative product DSPE-PEG-Mannose, an advanced…
Biopharma PEG Announces FDA DMF Registration for mPEG-pAld (20K)
Biopharma PEG, a leading manufacturer of high-quality polyethylene glycol (PEG) derivatives, today announced that its mPEG-pAld (20K) product has successfully achieved DMF (Drug Master File)…
Biopharma PEG Delivers Innovative PEG Solutions for Enhanced Drug Efficacy
Watertown, MA - October 24, 2024 - Biopharma PEG is excited to announce its extensive offerings of polyethylene glycol (PEG) products, including monofunctional, homobifunctional, heterobifunctional,…
Biopharma PEG Expands GMP Production of Lipids and PEGs to Meet Growing Demand f …
Biopharma PEG, a key provider of premium polyethylene glycol (PEG) derivatives, is thrilled to announce a substantial expansion of its large-scale Good Manufacturing Practice (GMP)…
Biopharma PEG Expands Multi-Arm PEG Product Line
Biopharma PEG, a leader in PEG derivatives, is excited to announce the expansion of its high-purity Multi-Arm PEG linker product line, catering to the evolving…
Biopharma PEG Launches New Monodispersed PEGs for Better Drug Delivery
Watertown, MA, July 22, 2024 - Biopharma PEG, a top supplier of PEG derivatives, is excited to introduce its new line of monodispersed PEGs.…
Biopharma PEG to Exhibit at BIO 2024 in San Diego
Biopharma PEG, a leading provider of advanced polyethylene glycol (PEG) derivatives, is excited to announce its participation in the BIO International Convention 2024, scheduled to…
Visit Biopharma PEG Scientific Inc. at PEGS Boston Summit and TIDES USA 2024
Biopharma PEG Scientific Inc., a pioneering biotechnology company based in Watertown, Massachusetts, is set to make a significant impact at the upcoming PEGS Boston Summit…
Biopharma PEG's Azide PEG Series for Pharmaceuticals
Biopharma PEG, a leading innovator in polyethylene glycol (PEG) derivatives, proudly introduces its featured Azide PEG series, which can be used in drug development, click…
Biopharma PEG Elevates ADC Development with Monodispersed PEGs in Versatile Scal …
Biopharma PEG is pleased to announce a groundbreaking advancement in the production of Antibody-Drug Conjugates (ADCs). The company now offers a diverse range of monodispersed…
Biopharma PEG Supplies PEG Products Used For Infectious Disease Vaccines
As of January 1, 2023, global vaccine development includes a total of 966 vaccine candidates, of which 23% (220) are traditional inactivated or attenuated vaccines.…
Optimization of Three Elements of ADC Drugs
Structurally, an ADC consists of monoclonal antibodies (Antibody) that target specific antigens on tumor surfaces, cytotoxic drugs (drugs) that kill tumor cells, and linkers (Conjugate/…
Go To Page:
